Objective To evaluate the comparative efficacy and safety of glucagon-like peptide-1
receptor agonists (GLP-1RAs) on glycaemic control, body weight, and lipid profile in adults …

Traditional approaches to prevention of the complications of type 2 diabetes (T2D) and
obesity have focused on reduction of blood glucose and body weight. The development of …

Incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1
RAs), have demonstrated cardiovascular benefits in people with type 2 diabetes. However …

Aim The present systematic review aimed to summarize the available evidence from
published randomized controlled trials (RCTs) regarding the effect of tirzepatide on …

Stroke represents a major burden in patients with type 2 diabetes, yet this cerebrovascular
complication has been less carefully investigated than the risk of cardiovascular mortality …

Background Sodium–glucose co-transporter-2 (SGLT2) inhibitors have been proposed as a
potential treatment for adults hospitalised with COVID-19, due to their potential anti …

Diabetes is a chronic disease that affects a vast number of individuals globally, and without
optimal treatment, can lead to significant health complications. Moreover, obesity is another …

The treatment of type 2 diabetes (T2D) necessitates a multifaceted approach that combines
behavioral and pharmacological interventions to mitigate complications and sustain a high …

Importance Metabolic dysfunction-associated steatotic liver disease (MASLD) is an
increasing cause of cirrhosis. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are …

Background We aimed to explore how probiotics, prebiotics, or synbiotics impact glycemic
indices in patients with diabetes mellitus. Method A comprehensive search was conducted …